Metabolism: A Bottleneck in In Vitro Toxicological Test Development

This is the 54th report of a series of workshops organised by the European Centre for the Validation of Alternative Methods (ECVAM). The main objective of ECVAM, as defined in 1993 by its Scientific Advisory Committee, is to promote the scientific and regulatory acceptance of alternative methods which are of importance to the biosciences, and which reduce, refine or replace the use of laboratory animals. One of the first priorities set by ECVAM was the implementation of procedures that would enable it to become well informed about the state-of-the-art of non-animal test development and validation, and of opportunities for the possible incorporation of alternative methods into regulatory procedures. It was decided that this would be best achieved through a programme of ECVAM workshops, each addressing a specific topic, and at which selected groups of independent international experts would review the current status of various types of in vitro tests and their potential uses, and make recommendations about the best ways forward. A workshop on Metabolism: a bottleneck in in vitro toxicological test development, was held at ECVAM on 26–29 January 2004, with participants Metabolism: A Bottleneck in In Vitro Toxicological Test Development

[1]  E. Testai,et al.  Multiple activation of chloroform in kidney microsomes from male and female DBA/2J mice. , 1994, Journal of biochemical toxicology.

[2]  M. Bailey,et al.  Acyl glucuronide reactivity in perspective: biological consequences. , 2003, Chemico-biological interactions.

[3]  S. Hotchkiss.  Skin as a xenobiotic metabolizing organ , 1992 .

[4]  Robert Combes,et al.  An Overall Strategy for the Testing of Chemicals for Human Hazard and Risk Assessment under the EU REACH System , 2003, Alternatives to laboratory animals : ATLA.

[5]  N. Roome,et al.  A New Hepatoma Cell Line for Toxicity Testing at Repeated Doses , 2003, Cell Biology and Toxicology.

[6]  G. Siest,et al.  Drug metabolizing enzymes in the brain and cerebral microvessels , 1991, Brain Research Reviews.

[7]  I. Sipes.  Contemporary issues in toxicology , 1988 .

[8]  M Cormier,et al.  Effect of proteins on the assessment of surfactant cytotoxicity by an in vitro test: Possible correlations with in vivo data. , 1987, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  Sabcho D Dimitrov,et al.  A systematic approach to simulating metabolism in computational toxicology. I. The TIMES heuristic modelling framework. , 2004, Current pharmaceutical design.

[10]  S Dimitrov,et al.  Probabilistic assessment of biodegradability based on metabolic pathways: CATABOL System , 2002, SAR and QSAR in environmental research.

[11]  T. Hartung,et al.  Alternatives to animal experimentation in basic research. , 2004, ALTEX.

[12]  A A Kousba,et al.  Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazinon. , 2004, Neurotoxicology.

[13]  H. Glatt,et al.  Sulfotransferases in the bioactivation of xenobiotics. , 2000, Chemico-biological interactions.

[14]  Hannu Raunio,et al.  Prediction of drug metabolism and interactions on the basis of in vitro investigations. , 2005, Basic & clinical pharmacology & toxicology.

[15]  G. Gervasini,et al.  Potential Role of Cerebral Cytochrome P450 in Clinical Pharmacokinetics , 2004, Clinical pharmacokinetics.

[16]  J. Veselý,et al.  Cell suspensions, cell cultures, and tissue slices--important metabolic in vitro systems. , 2001, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[17]  F. Guengerich.  Metabolism of chemical carcinogens. , 2000, Carcinogenesis.

[18]  Bas J Blaauboer,et al.  Modeling the in vitro intrinsic clearance of the slowly metabolized compound tolbutamide determined in sandwich-cultured rat hepatocytes. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[19]  Igor Goryanin,et al.  Mathematical simulation and analysis of cellular metabolism and regulation , 1999, Bioinform..

[20]  C. Elcombe,et al.  Alternatives to Aroclor 1254-induced S9 in in vitro genotoxicity assays. , 1992, Mutagenesis.

[21]  Robert Combes,et al.  An Assessment of Progress in the Use of Alternatives in Toxicity Testing since the Publication of the Report of the Second FRAME Toxicity Committee (1991) , 2002, Alternatives to laboratory animals : ATLA.

[22]  A. Clark,et al.  Use of microorganisms for the study of drug metabolism: An update , 1991, Medicinal research reviews.

[23]  T.M Walker,et al.  Cytochrome P450 activity in control and induced long-term cultures of rat hepatocyte spheroids. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[24]  J. Ghersi-Egea,et al.  Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations. , 2004, Advanced drug delivery reviews.

[25]  D. Lewis,et al.  Cytochromes P450: structure, function and mechanism. , 1996 .

[26]  E. Abourashed,et al.  Microbial models of mammalian metabolism of xenobiotics: An updated review. , 1999, Current medicinal chemistry.

[27]  J. Tarloff,et al.  Expression and activities of several drug-metabolizing enzymes in LLC-PK1 cells. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[28]  J. Cashman.  The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development. , 2004, Drug discovery today.

[29]  J. Castell,et al.  Re‐expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells , 1998 .

[30]  F. Oesch,et al.  Hepatocytes cultured in alginate microspheres: an optimized technique to study enzyme induction. , 2005, Toxicology.

[31]  X. Ponsoda,et al.  Human Hepatic Cell Cultures: In Vitro and In Vivo Drug Metabolism , 2003, Alternatives to laboratory animals : ATLA.

[32]  Wolf Cr,et al.  Transgenic analysis of human drug-metabolizing enzymes: preclinical drug development and toxicology. , 2003 .

[33]  Silvio Albertini,et al.  Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  Ding‐Shinn Chen,et al.  Long-Term Culture of Hepatocytes from Human Adults , 1998, Journal of Biomedical Science.

[35]  H. Glatt,et al.  Expression of xenobiotic-metabolizing enzymes in propagatable cell cultures and induction of micronuclei by 13 compounds. , 1990, Mutagenesis.

[36]  A. Clark,et al.  The use of microorganisms for the study of drug metabolism , 1985, Medicinal research reviews.

[37]  B. Isomaa,et al.  Development of an In Vitro Test Battery for the Estimation of Acute Human Systemic Toxicity: An Outline of the EDIT Project , 2002, Alternatives to laboratory animals : ATLA.

[38]  J. Douglas,et al.  Bioactivation of 5-hydroxymethyl-2-furaldehyde to an electrophilic and mutagenic allylic sulfuric acid ester. , 1995, Biochemical and biophysical research communications.

[39]  Walter Luyten,et al.  Genetically Engineered Cell Lines: Characterisation and Applications in Toxicity Testing , 1997 .

[40]  C. Cerniglia,et al.  Biotransformation of Malachite Green by the FungusCunninghamella elegans , 2001, Applied and Environmental Microbiology.

[41]  O. Pelkonen,et al.  Metabolic activation of toxins: tissue-specific expression and metabolism in target organs. , 1997, Environmental health perspectives.

[42]  A. Pfeifer,et al.  18 – Drug Metabolism and Carcinogen Activation Studies with Human Genetically Engineered Cells , 1996 .

[43]  T Hartung,et al.  The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development. , 2004, Current pharmaceutical design.

[44]  Chris de Graaf,et al.  Cytochrome p450 in silico: an integrative modeling approach. , 2005, Journal of medicinal chemistry.

[45]  J. Raucy,et al.  Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[46]  C. Ioannides.  Enzyme Systems that Metabolise Drugs and Other Xenobiotics , 2001 .

[47]  C. Guinchard,et al.  Time course of cytochromes P450 decline during rat hepatocyte isolation and culture: effect of L-NAME. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[48]  J. Pico,et al.  Alternatives in the induction and preparation of phenobarbital/naphthoflavone-induced S9 and their activation profiles. , 1999, Mutagenesis.

[49]  R. Ian Freshney,et al.  Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications , 2010 .

[50]  Aldert Piersma,et al.  The ECVAM International Validation Study on In Vitro Embryotoxicity Tests: Results of the Definitive Phase and Evaluation of Prediction Models , 2002, Alternatives to laboratory animals : ATLA.

[51]  C. Prakash,et al.  CHARACTERIZATION OF A NOVEL METABOLITE INTERMEDIATE OF ZIPRASIDONE IN HEPATIC CYTOSOLIC FRACTIONS OF RAT, DOG, AND HUMAN BY ESI-MS/MS, HYDROGEN/DEUTERIUM EXCHANGE, AND CHEMICAL DERIVATIZATION , 2005, Drug Metabolism and Disposition.

[52]  D. Lewis,et al.  Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: investigation of enzyme-substrate and enzyme-inhibitor interactions. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[53]  J. Castell,et al.  Functionality of cultured human hepatocytes from elective samples, cadaveric grafts and hepatectomies. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[54]  R. Tyndale,et al.  The Unique Regulation of Brain Cytochrome P450 2 (CYP2) Family Enzymes by Drugs and Genetics , 2004, Drug metabolism reviews.

[55]  V. Rogiers,et al.  Effect of epidermal growth factor in collagen gel cultures of rat hepatocytes. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[56]  P. H. Bach,et al.  Nephrotoxicity Testing In Vitro , 1995 .

[57]  R. Combes.  The Case for Taking Account of Metabolism when Testing for Potential Endocrine Disruptors In Vitro , 2004, Alternatives to laboratory animals : ATLA.

[58]  T. Eling,et al.  Prostaglandin H synthase and xenobiotic oxidation. , 1990, Annual review of pharmacology and toxicology.

[59]  W. Bidlack.  Casarett & Doull’s Toxicology: The Basic Science of Poisons, 6th ed. , 2002 .

[60]  A Worth,et al.  The use of genetically engineered cells for assessing CYP2D6-related polymorphic effects. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[61]  D. Lewis,et al.  Molecular modelling of human microsomal epoxide hydrolase (EH) by homology with a fungal (Aspergillus niger) EH crystal structure of 1.8 A resolution: structure-activity relationships in epoxides inhibiting EH activity. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[62]  M A Butler,et al.  Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. , 1992, Environmental health perspectives.

[63]  N. Chauret,et al.  Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[64]  A. Li,et al.  Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[65]  D. Lewis,et al.  Cytochromes P450 in the bioactivation of chemicals. , 2004, Current topics in medicinal chemistry.

[66]  Masaki Nishikawa,et al.  Feasibility of a simple double-layered coculture system incorporating metabolic processes of the intestine and liver tissue: application to the analysis of benzo[a]pyrene toxicity. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[67]  V. Rogiers,et al.  Effect of the aging process on the gender and phenobarbital dependent expression of glutathione S-transferase subunits in brown Norway rat liver. , 1991, Biochemical pharmacology.

[68]  S Coecke,et al.  The use of Long-term Hepatocyte Cultures for Detecting Induction of Drug Metabolising Enzymes: The Current Status , 1999, Alternatives to laboratory animals : ATLA.

[69]  André Guillouzo,et al.  EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS , 2006, Drug Metabolism and Disposition.

[70]  B. W. Penman,et al.  Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. , 1997, Analytical biochemistry.

[71]  Romualdo Benigni,et al.  The Development and Validation of Expert Systems for Predicting Toxicity The Report and Recommendations of an ECVAM / ECB Workshop ( ECVAM Workshop 24 ) , 2002 .

[72]  Worth Andrew,et al.  Alternative (Non-Animal) Methods for Chemicals Testing: Current Status and Future Prospects (A Report Prepared by ECVAM and the ECVAM WG on Chemicals) , 2002 .

[73]  M. Relling,et al.  Pharmacogenomics: translating functional genomics into rational therapeutics. , 1999, Science.

[74]  E. Testai,et al.  Toxicology investigations with cell culture systems: 20 years after. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[75]  R. de Kanter,et al.  Phase I and phase II metabolic activities are retained in liver slices from mouse, rat, dog, monkey and human after cryopreservation. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[76]  R. Combes.  The in vivo relevance of in vitro genotoxicity assays incorporating enzyme activation systems , 1992 .

[77]  Slobodan Petar Rendic.  Summary of information on human CYP enzymes: human P450 metabolism data , 2002, Drug metabolism reviews.

[78]  Thomas Hartung,et al.  Developmental toxicity testing from animal towards embryonic stem cells. , 2005, ALTEX.

[79]  R. Kim.  Transporters and xenobiotic disposition. , 2002, Toxicology.

[80]  E. Banoglu.  Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. , 2000, Current drug metabolism.

[81]  P. H. Bach,et al.  The Use of Tissue Slices for Pharmacotoxicology Studies , 1996 .

[82]  C. Bradfield,et al.  Generation of allelic series in mice by gene targeting. , 1998, Methods in molecular biology.

[83]  Philip N. Judson,et al.  Using Absolute and Relative Reasoning in the Prediction of the Potential Metabolism of Xenobiotics , 2003, J. Chem. Inf. Comput. Sci..

[84]  H. Glatt,et al.  Search for cell culture systems with diverse xenobiotic-metabolizing activities and their use in toxicological studies. , 1987, Molecular toxicology.

[85]  N. Plant.  Strategies for using in vitro screens in drug metabolism. , 2004, Drug discovery today.

[86]  A. Dennison,et al.  A Survey of Consumer Attitudes to the Supply and Use of Human Hepatocytes in the United Kingdom , 2003, Alternatives to laboratory animals : ATLA.

[87]  B. W. Penman,et al.  Use of cDNA-expressed human cytochrome P450 enzymes to study potential drug-drug interactions. , 1997, Advances in pharmacology.

[88]  T. Vanhaecke,et al.  Effect of the histone deacetylase inhibitor trichostatin A on spontaneous apoptosis in various types of adult rat hepatocyte cultures. , 2004, Biochemical pharmacology.

[89]  P. Maier,et al.  Short-term assay for the identification of neurotoxic compounds and their liver derived stable metabolites. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[90]  H Seibert,et al.  Influence of protein binding and lipophilicity on the distribution of chemical compounds in in vitro systems. , 1997, Toxicology in vitro : an international journal published in association with BIBRA.

[91]  R. Ian Fresh,et al.  Culture of animal cells : a manual of basic technique , 2005 .

[92]  B. Testa,et al.  Predicting drug metabolism: Concepts and challenges , 2004 .

[93]  R. Guy,et al.  Methods for Assessing Percutaneous Absorption , 1996 .

[94]  J B Houston,et al.  An Integrated Approach to the Prediction of Systemic Toxicity using Computer-based Biokinetic Models and Biological In vitro Test Methods: Overview of a Prevalidation Study Based on the ECITTS Project. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[95]  D W Gaylor,et al.  Risk assessment of nongenotoxic carcinogens based upon cell proliferation/death rates in rodents. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.

[96]  F W Schildberg,et al.  Protein binding capacity in vitro changes metabolism of substrates and influences the predictability of metabolic pathways in vivo. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[97]  P. Neuhaus,et al.  Induction, expression and maintenance of cytochrome P450 isoforms in long-term cultures of primary human hepatocytes. , 2004, ALTEX.

[98]  J. Waring,et al.  Isolated human hepatocytes in culture display markedly different gene expression patterns depending on attachment status. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[99]  Philip N. Judson,et al.  Using Argumentation for Absolute Reasoning about the Potential Toxicity of Chemicals , 2003, J. Chem. Inf. Comput. Sci..

[100]  O. Pelkonen,et al.  In Vitro Methods in the Prediction of Kinetics of Drugs: Focus on Drug Metabolism , 2004, Alternatives to laboratory animals : ATLA.

[101]  M. Brewster,et al.  The use of human nasal in vitro cell systems during drug discovery and development. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[102]  V. Rogiers,et al.  Hepatic cytosolic glutathione S-transferase activities in ageing Brown Norway rats — Importance of sex differences and phenobarbital treatment for studies of ageing , 1990, Mechanisms of Ageing and Development.

[103]  Xinxin Ding,et al.  Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. , 2003, Annual review of pharmacology and toxicology.

[104]  C. Wolf,et al.  Transgenic analysis of human drug-metabolizing enzymes: preclinical drug development and toxicology. , 2003, Molecular interventions.

[105]  E. Morgan.  Regulation of cytochrome p450 by inflammatory mediators: why and how? , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[106]  Andrew Worth,et al.  The Registry of Cytotoxicity: Toxicity Testing in Cell Cultures to Predict Acute Toxicity (LD50) and to Reduce Testing in Animals 1 , 2003, Alternatives to laboratory animals : ATLA.

[107]  G. Hamilton,et al.  Evaluation of the effect of culture configuration on morphology, survival time, antioxidant status and metabolic capacities of cultured rat hepatocytes. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[108]  Munir Pirmohamed,et al.  The role of metabolic activation in drug-induced hepatotoxicity. , 2005, Annual review of pharmacology and toxicology.

[109]  S. Bremer,et al.  Detection of the Embryotoxic Potential of Cyclophosphamide by Using a Combined System of Metabolic Competent Cells and Embryonic Stem Cells , 2002, Alternatives to laboratory animals : ATLA.

[110]  O. Pelkonen,et al.  Interindividual variability in human drug metabolism , 2001 .

[111]  A. Guillouzo,et al.  Liver cell models in in vitro toxicology. , 1998, Environmental health perspectives.

[112]  R. Gebhardt,et al.  Improved Determination of Drug Metabolism by Perifusion of Recombinant V79 Cells Carrying Human CYP3A4. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[113]  A. Pfeifer,et al.  Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[114]  T. Baillie,et al.  Drug metabolites in safety testing. , 2002, Toxicology and applied pharmacology.

[115]  Susanne Bremer,et al.  Validation of the Embryonic Stem Cell Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.

[116]  R. de la Torre,et al.  Serotonergic Neurotoxic Metabolites of Ecstasy Identified in Rat Brain , 2005, Journal of Pharmacology and Experimental Therapeutics.

[117]  Hanneke van Helvoort,et al.  THE USE OF SANDWICH-CULTURED RAT HEPATOCYTES TO DETERMINE THE INTRINSIC CLEARANCE OF COMPOUNDS WITH DIFFERENT EXTRACTION RATIOS: 7-ETHOXYCOUMARIN AND WARFARIN , 2005, Drug Metabolism and Disposition.

[118]  O Pelkonen,et al.  Inhibition and induction of human cytochrome P450 (CYP) enzymes. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[119]  Valérie Zuang,et al.  Dendritic Cells as a Tool for the Predictive Identification of Skin Sensitisation Hazard , 2005, Alternatives to laboratory animals : ATLA.

[120]  J. Castell,et al.  In vitro methods in pharmaceutical research , 1997 .

[121]  M. T. Donato,et al.  Evaluation of the xenobiotic biotransformation capability of six rodent hepatoma cell lines in comparison with rat hepatocytes , 1994, In Vitro Cellular & Developmental Biology - Animal.

[122]  D. Nebert,et al.  Expression of the mouse P(1)450 gene during differentiation without foreign chemical stimulation. , 1987, Journal of experimental pathology.

[123]  Horst Spielmann,et al.  Validation Successes: Chemicals , 2002, Alternatives to laboratory animals : ATLA.

[124]  H. Samaratunga,et al.  Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[125]  E Sabbioni,et al.  Cell Transformation Assays as Predictors of Human Carcinogenicity , 1999, Alternatives to laboratory animals : ATLA.

[126]  R D Combes,et al.  The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens. , 2000, Toxicology in vitro : an international journal published in association with BIBRA.

[127]  D. Lewis,et al.  Homology modelling of CYP2A6 based on the CYP2C5 crystallographic template: enzyme-substrate interactions and QSARs for binding affinity and inhibition. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[128]  I. Stupans,et al.  Immunohistochemical localization of NADPH-cytochrome P450 reductase in human tissues. , 1989, Carcinogenesis.

[129]  J B Houston,et al.  The Integrated Use of Alternative Methods in Toxicological Risk Evaluation , 1999, Alternatives to laboratory animals : ATLA.

[130]  S. Ekins,et al.  Present and future in vitro approaches for drug metabolism. , 2000, Journal of pharmacological and toxicological methods.

[131]  M Ishidate,et al.  Transformation of ras transfected BALB 3T3 clone (Bhas 42) by promoters: Application for screening and specificity of promoters. , 1990, Toxicology in vitro : an international journal published in association with BIBRA.

[132]  D. Jonas,et al.  Phosphorylation of hepatocyte growth factor receptor and epidermal growth factor receptor of human hepatocytes can be maintained in a (3D) collagen sandwich culture system. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[133]  O. Pelkonen,et al.  In vitro screening of drug metabolism during drug development: can we trust the predictions? , 2005, Expert opinion on drug metabolism & toxicology.

[134]  G. Scholz,et al.  Endocrine toxicology--contributions of in vitro methods to the 3R concept. , 2004, ALTEX.

[135]  D. Nebert,et al.  Drug metabolic enzymes in developmental toxicology. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[136]  Robert Combes,et al.  Intelligent Testing Strategies for Chemicals Testing — A Case of More Haste, Less Speed? , 2005, Alternatives to laboratory animals : ATLA.

[137]  D. Lewis,et al.  Quantitative structure-activity relationships (QSARs) for substrates of human cytochromes P450 CYP2 family enzymes. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[138]  R. Kahl,et al.  Binding of benzo(a)pyrene metabolites to cellular DNA in perfused rat lungs , 1978, Naunyn-Schmiedeberg's Archives of Pharmacology.

[139]  H. Glatt,et al.  Heterologous Expression of Mouse Cytochrome P450 2e1 in V79 Cells: Construction and Characterisation of the Cell Line and Comparison with V79 Cell Lines Stably Expressing Rat P450 2E1 and Human P450 2E1 , 2003, Alternatives to laboratory animals : ATLA.

[140]  C Westmoreland,et al.  Comparison of Hepatocyte Cultures and Liver Slices in In Vitro Toxicity Testing , 1999, Alternatives to laboratory animals : ATLA.

[141]  J B Houston,et al.  Pharmacokinetics in Early Drug Research , 1997, Alternatives to laboratory animals : ATLA.

[142]  M. W. Anders.  Glutathione‐dependent Bioactivation of Haloalkanes and Haloalkenes , 2004, Drug metabolism reviews.

[143]  P. Taavitsainen.  Cytochrome P450 isoform-specific in vitro methods to predict drug metabolism and interactions , 2001 .

[144]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[145]  Emanuela Corsini,et al.  Alternative Methods for Skin Sensitisation Testing , 1996 .

[146]  P. Pour,et al.  Species Differences in the Distribution of Drug-Metabolizing Enzymes in the Pancreas , 2002, Toxicologic pathology.

[147]  A. Y. Lu,et al.  Role of pharmacokinetics and metabolism in drug discovery and development. , 1997, Pharmacological reviews.

[148]  E. Lock,et al.  Symposium overview: the role of glutathione in neuroprotection and neurotoxicity. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[149]  M. Namba,et al.  Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[150]  S. Bull,et al.  A Genetically Engineered Cell-based System for Detecting Metabolism-mediated Toxicity , 2001, Alternatives to laboratory animals : ATLA.

[151]  T. Vanhaecke,et al.  Differential Effects of Histone Deacetylase Inhibitors in Tumor and Normal Cells—What Is the Toxicological Relevance? , 2005, Critical reviews in toxicology.

[152]  P. Grasso,et al.  The Use of the Dog in Toxicity Tests on Pharmaceutical Compounds , 1993, Human & experimental toxicology.

[153]  C. Guguen-Guillouzo,et al.  Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2. , 2001, European journal of biochemistry.

[154]  A. Bogni,et al.  Metabolism and Neurotoxicity: The Significance of Genetically Engineered Cell Lines and New Three-Dimensional Cell Cultures , 2002, Alternatives to laboratory animals : ATLA.

[155]  S. Fennrich,et al.  Drug metabolism in in vitro organotypic and cellular models of mammalian central nervous system: activities of membrane-bound epoxide hydrolase and NADPH-cytochrome P-450 (c) reductase. , 1998, Neurotoxicology.

[156]  C Timchalk,et al.  A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[157]  A. Dipple,et al.  Limitations of metabolic activation systems used with in vitro tests for carcinogens. , 1980, Science.

[158]  C. Funk,et al.  Use of transgenic cell lines in mechanistic studies of drug metabolism. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[159]  Robert D. Combes,et al.  14 – In Vitro Genotoxicity and Cell Transformation Assessment , 1996 .

[160]  C. Masimirembwa,et al.  Heterologous expression and kinetic characterization of human cytochromes P-450: validation of a pharmaceutical tool for drug metabolism research. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[161]  J. Hakkola,et al.  Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity. , 1998, Critical reviews in toxicology.

[162]  M. Ingelman-Sundberg,et al.  Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[163]  C. Wolf,et al.  Endogenous xenobiotic enzyme levels in mammalian cells. , 1991, Mutation research.

[164]  Robert D Combes,et al.  The Use of Human Cells in Biomedical Research and Testing , 2004, Alternatives to laboratory animals : ATLA.

[165]  Amy Roe,et al.  The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[166]  J B Houston,et al.  In vitro human tissue models in risk assessment: report of a consensus-building workshop. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[167]  F. Gonzalez.  Cytochrome P450 humanised mice , 2004, Human Genomics.

[168]  T. Koda,et al.  Estrogenic activity of 37 components of commercial sunscreen lotions evaluated by in vitro assays. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[169]  Robert Combes,et al.  The Use of Expert Systems for Toxicity Prediction: Illustrated with Reference to the DEREK Program , 2004 .

[170]  A. Prenez,et al.  Use of primary cultures of rat hepatocytes to predict toxicity in the early development of new chemical entities. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[171]  C. Crespi.  Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research , 1995 .

[172]  Dominic P. Williams,et al.  Idiosyncratic toxicity: the role of toxicophores and bioactivation. , 2003, Drug discovery today.

[173]  A. J. Gandolfi,et al.  Precision-cut tissue slices from transgenic mice as an in vitro toxicology system. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[174]  B. Hammock,et al.  Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. , 2005, Annual review of pharmacology and toxicology.

[175]  J. Parry.  A Summary of the Effects of Benzidine, 4,4″-Diaminoterphenyl, 4-Dimethylaminoazobenzene and 4-Cyanodimethylaniline as Observed by the Yeast Group in the Second UKEMS Collaborative Study , 1985 .

[176]  B J Blaauboer,et al.  An alternative approach for the safety evaluation of new and existing chemicals, an exercise in integrated testing. , 2005, Regulatory toxicology and pharmacology : RTP.

[177]  L. Bertilsson,et al.  Genetically variable metabolism of antidepressants and neuroleptic drugs in man. , 1993, Pharmacogenetics.

[178]  C. Urani,et al.  Human-derived cell lines to study xenobiotic metabolism. , 1998, Chemosphere.

[179]  Christian Trepo,et al.  Infection of a human hepatoma cell line by hepatitis B virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[180]  S Dimitrov,et al.  In silico modelling of hazard endpoints: current problems and perspectives , 2003, SAR and QSAR in environmental research.

[181]  X. Ponsoda,et al.  Drug Metabolism by Cultured Human Hepatocytes: How Far are we from the In Vivo Reality? , 2004, Alternatives to laboratory animals : ATLA.

[182]  M. Garle,et al.  A Preliminary Comparison of LiverBeads™ with a Conventional Rat Hepatocyte Culture Preparation: Some Aspects of Xenobiotic Metabolism and Related Toxicity , 1999, Alternatives to laboratory animals : ATLA.

[183]  J. Hermens,et al.  Computer-modeling-based QSARs for analyzing experimental data on biotransformation and toxicity. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[184]  Martin P. Payne,et al.  Computer-Based Methods for the Prediction of Chemical Metabolism and Biotransformation within Biological Organisms , 2004 .

[185]  Vera Rogiers,et al.  3.9. Toxicokinetics and Metabolism , 2005, Alternatives to laboratory animals : ATLA.

[186]  M. Butler,et al.  Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. , 1991, Carcinogenesis.

[187]  Thomas Hartung,et al.  The value of alternative testing for neurotoxicity in the context of regulatory needs. , 2006, Environmental toxicology and pharmacology.

[188]  D. Lewis.  Guide to Cytochromes P450 : structure and function , 2001 .

[189]  O. Pelkonen,et al.  A simple method for differentiation of monoisotopic drug metabolites with hydrogen-deuterium exchange liquid chromatography/electrospray mass spectrometry. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[190]  S. Clarke.  In vitro assessment of human cytochrome P450. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[191]  Ian R. Phillips,et al.  Cytochrome P450 Protocols , 2013, Methods in Molecular Biology.

[192]  B Ekwall,et al.  Overview of the Final MEIC Results: II. The In Vitro--In Vivo Evaluation, Including the Selection of a Practical Battery of Cell Tests for Prediction of Acute Lethal Blood Concentrations in Humans. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[193]  Panos Macheras,et al.  In silico prediction of ADME and pharmacokinetics. Report of an expert meeting organised by COST B15. , 2002, European Journal of Pharmaceutical Sciences.

[194]  M. Aardema,et al.  Use of Syrian hamster embryo and BALB/c 3T3 cell transformation for assessing the carcinogenic potential of chemicals. , 1999, IARC scientific publications.

[195]  Magnus Ingelman-Sundberg,et al.  Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[196]  N. Vermeulen,et al.  Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway. , 1995, Chemical research in toxicology.